-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Finance App News, Hengrui Pharmaceutical (01276.HK) announced that recently, Beijing Shengdi Pharmaceutical Co., Ltd., a subsidiary of the company, received a notice from the State Drug Administration to approve the launch of a Class 1 new drug independently developed by the company.

Zhitongcaijing·11/12/2026 09:33:04
Listen to the news
Zhitong Finance App News, Hengrui Pharmaceutical (01276.HK) announced that recently, Beijing Shengdi Pharmaceutical Co., Ltd., a subsidiary of the company, received a notice from the State Drug Administration to approve the launch of a Class 1 new drug independently developed by the company.